Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Currently available radiological methods do not completely capture the diversity of multiple sclerosis (MS) lesion subtypes. This lack of information hampers the understanding of disease progression and potential treatment stratification. For example, inflammation persists in some lesions after gadolinium (Gd) enhancement resolves. Novel metabolic and molecular imaging methods may improve the current assessments of MS pathophysiology.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Purpose</h3><p>To compare the in vivo proton exchange rate (<i>k</i><sub><i>ex</i></sub>) MRI with Gd‐enhanced MRI for characterizing MS lesions. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Study Type</h3><p>Retrospective.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Subjects</h3><p>Sixteen consecutively diagnosed relapsing‐remitting multiple sclerosis (RRMS) patients.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Field Strength/Sequence</h3><p>3.0T MRI with T<sub>2</sub>‐weighted imaging, postcontrast T<sub>1</sub>‐weighted imaging, and single‐slice chemical exchange saturation transfer imaging. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Assessment</h3><p>MS lesions in white matter were assessed for Gd enhancement and <i>k</i><sub><i>ex</i></sub> elevation compared to normal‐appearing white matter (NAWM). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Statistical Tests</h3><p>Student's <i>t‐</i>test was used for analyzing the difference of <i>k</i><sub><i>ex</i></sub> values between lesions and NAWM, with statistical significance set at 0.05. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Of all 153 MS lesions, 78 (51%) lesions were Gd‐enhancing and 75 (49%) were Gd‐negative. Without exception, all 78 Gd‐enhancing lesions showed significantly elevated <i>k</i><sub><i>ex</i></sub> values compared to NAWM (924 ± 130 s<sup>–1</sup> vs. 735 ± 61 s<sup>–1</sup>, <i>P</i> < 0.05). Of 75 Gd‐negative lesions, 18 lesions (24%) showed no <i>k</i><sub><i>ex</i></sub> elevation (762 ± 29 s<sup>–1</sup> vs. 755 ± 28 s<sup>–1</sup>, <i>P</i> = 0.47) and 57 (76%) showed significant <i>k</i><sub><i>ex</i></sub> elevation (950 ± 124 s<sup>–1</sup> vs. 759 ± 48 s<sup>–1</sup>, <i>P</i> < 0.05) compared to NAWM. MS lesions with <i>k</i><sub><i>ex</i></sub> elevation appeared nodular (118, 87.4%), ring‐like (15, 11.1%), or irregular‐shaped (2, 1.5%). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Data Conclusion</h3><p>For Gd‐enhancing lesions, <i>k</i><sub><i>ex</i></sub> MRI is highly consistent with Gd‐enhanced images by showing 100% of elevated <i>k</i><sub><i>ex</i></sub>. For all Gd‐negative lesions, the discrepancy on <i>k</i><sub><i>ex</i></sub> MRI may further differentiate active slowly expanding lesions or chronic inactive lesions, supporting <i>k</i><sub><i>ex</i></sub> as an imaging biomarker for tissue oxidative stress and inflammation. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Level of Evidence</h3><p>2</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Technical Efficacy Stage</h3><p>3</p></section>

In Vivo Proton Exchange Rate ( k ex ) MRI for the Characterization of Multiple Sclerosis Lesions in Patients

Combining in vivo proton exchange rate (kex) MRI with quantitative susceptibility mapping to further stratify the gadolinium-negative multiple sclerosis lesions

Novel Proton Exchange Rate MRI Presents Unique Contrast in Brains of Ischemic Stroke Patients

Single scan quantitative gradient recalled echo MRI for evaluation of tissue damage in lesions and normal appearing gray and white matter in multiple sclerosis

Contrast-enhanced Digital Subtraction MRI in Vertebral Metastases

A Comparison of Magnetic Resonance Imaging Methods to Assess Multiple Sclerosis Lesions: Implications for Patient Characterization and Clinical Trial Design

Differentiation between cerebral metastases , meningiomas , and primary gliomas by dynamic contrast-enhanced MRI

A Contrast Examination of Proinflammatory Effects on Kidney Function for γ-Fe2O3 NP and Gadolinium Dimeglumine

Intraindividual In Vivo Comparison Of Gadolinium Contrast Agents For Pharmacokinetic Analysis Using Dynamic Contrast Enhanced Magnetic Resonance Imaging

Measurement of the Permeability, Perfusion, and Histogram Characteristics in Relapsing-Remitting Multiple Sclerosis Using Dynamic Contrast-Enhanced MRI with Extended Tofts Linear Model.

Analysis of Clinical Diagnostic Value of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Combined with MRI in Early Breast Cancer

[The Characteristics of Enhanced Gadolinium DTPA Brain Magnetic Resonance Images in 298 Multiple Sclerosis Patients].

Quantitative assessment of liver function with hepatocyte fraction: Comparison with T1 relaxation‐based indices

Intra-Individual Comparison of Different Gadolinium-Based Contrast Agents in the Quantitative Evaluation of C6 Glioma with Dynamic Contrast-Enhanced Magnetic Resonance Imaging

Longitudinal microstructural MRI markers of demyelination and neurodegeneration in early relapsing-remitting multiple sclerosis: Magnetisation transfer, water diffusion and g-ratio

Tissue damage detected by quantitative gradient echo MRI correlates with clinical progression in non-relapsing progressive MS

Detection and Quantification of Regional Cortical Gray Matter Damage in Multiple Sclerosis Utilizing Gradient Echo Mri

Low-dose Contrast-Enhanced Magnetic Resonance Imaging of Brain Metastases at 3.0 T Using High-Relaxivity Contrast Agents.

Utility of Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Differentiating Glioblastoma, Primary Central Nervous System Lymphoma and Brain Metastatic Tumor.

Improving the Detection of Myelin Integrity in Multiple Sclerosis Using Selective Inversion Recovery for MRI With Quantitative Magnetization Transfer

Intra-individueller In-vivo-Vergleich Von Gd-haltigen MR-Kontrastmitteln Mit Dynamischer Kontrastmittelunterstützter MRT Bei 7T